SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147S334.
  • 2
    Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106(Suppl. 5):S201S205.
  • 3
    Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109: 419425.
  • 4
    Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301304.
  • 5
    Plaschke PP, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000;162:920924.
  • 6
    Montnemery P, Svensson C, Adelroth E, Lofdahl CG, Andersson M, Greiff L et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001;17:596603.
  • 7
    Roberts NJ, Lloyd-Owen SJ, Rapado F, Patel IS, Wilkinson TM, Donaldson GC et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med 2003;97:909914.
  • 8
    Hurst JR, Wilkinson TM, Donaldson GC, Wedzicha JA. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respir Med 2004;98:767770.
  • 9
    Sahin-Yilmaz AA, Corey JP. Rhinitis in the elderly. Clin Allergy Immunol 2007;19:209219.
  • 10
    Romanet-Manent S, Charpin D, Magnan A, Lanteaume A, Vervloet D. Allergic vs nonallergic asthma: what makes the difference? Allergy 2002;57:607613.
  • 11
    Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6037 patients. J Allergy Clin Immunol 1977;59:1721.
  • 12
    Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA. Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2004;34:891896.
  • 13
    Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA. Correlation of nasal inflammation and nasal airflow with forced expiratory volume in 1 second in patients with perennial allergic rhinitis and asthma. Ann Allergy Asthma Immunol 2004;93:575580.
  • 14
    Hurst JR, Wilkinson TM, Perera WR, Donaldson GC, Wedzicha JA. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD. Chest 2005;127:12191226.
  • 15
    Vachier I, Vignola AM, Chiappara G, Bruno A, Meziane H, Godard P et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004;59:303307.
  • 16
    Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-item sino-nasal outcome test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:4147.
  • 17
    Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000;162:22952301.
  • 18
    Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109115.
  • 19
    Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006;61:202208.
  • 20
    Quaedvlieg V, Henket M, Sele J, Louis R. Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clin Exp Immunol 2006;143:161166.
  • 21
    Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against “intrinsic” asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:14971504.
  • 22
    Menz G, Ying S, Durham SR, Corrigan CJ, Robinson DS, Hamid Q et al. Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma. Allergy 1998;53(Suppl. 45):1521.
  • 23
    Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4:619625.
  • 24
    Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515548.
  • 25
    Franzke A. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 2006;17:235244.
  • 26
    Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002;26:748753.